Toshiyuki Mori

Toshiyuki Mori is an External Director and Chair of the Audit and Supervisory Committee at J-Pharma Co., Ltd., a pharmaceutical company based in Japan.1 His role involves overseeing corporate governance and ensuring efficient and effective management practices within the company.

Professional Experience

Toshiyuki Mori has experience serving on the boards of multiple companies:

1. J-Pharma Co., Ltd.: Currently serves as External Director and Chair of the Audit and Supervisory Committee.1
2. Morico: Previously held a position as a Board Member.2

Involvement with J-Pharma

As part of J-Pharma's corporate governance structure, Mori plays a crucial role in maintaining transparency with shareholders and other stakeholders.1 His position on the Audit and Supervisory Committee is particularly important, as J-Pharma has chosen a "company with Audit and Supervisory Committee" structure to match the scale and nature of their business.1

Industry Engagement

Mori appears to be actively involved in promoting J-Pharma's developments in the pharmaceutical industry. In January 2023, he shared an announcement about J-Pharma's lead oncology product candidate, Nanvuranlat, being featured at the ASCO Gastrointestinal Cancers symposium.3 This suggests that he takes an active interest in the company's research and development efforts, particularly in the field of oncology.

While specific details about Toshiyuki Mori's background and qualifications are not provided in the available information, his position as an External Director and Chair of the Audit and Supervisory Committee indicates that he likely brings valuable expertise and an independent perspective to J-Pharma's governance structure.